Intrathecal opioids for the management of post-operative pain

IF 4.7 3区 医学 Q1 ANESTHESIOLOGY Best Practice & Research-Clinical Anaesthesiology Pub Date : 2023-06-01 DOI:10.1016/j.bpa.2023.01.001
Narinder Rawal (Professor)
{"title":"Intrathecal opioids for the management of post-operative pain","authors":"Narinder Rawal (Professor)","doi":"10.1016/j.bpa.2023.01.001","DOIUrl":null,"url":null,"abstract":"<div><p>Intrathecal opioids are highly effective in the management of post-operative pain. The technique is simple with a very low risk of technical failure or complications, and it does not require additional training or expensive equipment such as ultrasound machines and, therefore, is widely practised around the world. The high-quality pain relief is not associated with sensory, motor or autonomic deficits. This study focuses on intrathecal morphine (ITM) which is the only US Food and Drug Administration-approved opioid for intrathecal administration and remains the most commonly used as well as extensively studied. The use of ITM is associated with prolonged analgesia lasting 20–48 h after a variety of surgical procedures. ITM has a well-established role in thoracic, abdominal, spinal, urological and orthopaedic surgeries. It is considered the ‘gold standard’ analgesia technique for caesarean delivery which is generally performed under spinal anaesthesia. As the role of epidural technique in post-operative pain management continues to decrease, ITM has emerged as the neuraxial technique of choice for pain management after a major surgery as a component of multimodal analgesia in Enhanced Recovery After Surgery (ERAS) protocols. ITM is recommended by many scientific groups and societies such as ERAS, PROSPECT, the National Institute for Health and Care Excellence and the Society of Obstetric Anesthesiology and Perinatology. The doses of ITM have decreased successively; today they are a fraction of those used in the early 1980s. With these dose reductions, the risks have decreased; current evidence shows that the risk of the much-feared respiratory depression with low-dose ITM (up to 150 mcg) is no greater than that with systemic opioids used in routine clinical practice. Patients receiving low-dose ITM can be nursed in regular surgical wards. The monitoring recommendations from societies such as the European Society of Regional Anaesthesia and Pain Therapy (ESRA), the American Society of Regional Anesthesia and Pain Medicine and the American Society of Anesthesiologists need to be updated so that the requirements for extended or continuous monitoring at postoperative care units (PACUs), step-down units, high-dependency units, and intensive care units can be eliminated, thereby reducing additional costs and inconvenience and making this simple, versatile and highly effective analgesia technique available to a wider patient population in resource-limited settings.</p></div>","PeriodicalId":48541,"journal":{"name":"Best Practice & Research-Clinical Anaesthesiology","volume":"37 2","pages":"Pages 123-132"},"PeriodicalIF":4.7000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Best Practice & Research-Clinical Anaesthesiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1521689623000046","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Intrathecal opioids are highly effective in the management of post-operative pain. The technique is simple with a very low risk of technical failure or complications, and it does not require additional training or expensive equipment such as ultrasound machines and, therefore, is widely practised around the world. The high-quality pain relief is not associated with sensory, motor or autonomic deficits. This study focuses on intrathecal morphine (ITM) which is the only US Food and Drug Administration-approved opioid for intrathecal administration and remains the most commonly used as well as extensively studied. The use of ITM is associated with prolonged analgesia lasting 20–48 h after a variety of surgical procedures. ITM has a well-established role in thoracic, abdominal, spinal, urological and orthopaedic surgeries. It is considered the ‘gold standard’ analgesia technique for caesarean delivery which is generally performed under spinal anaesthesia. As the role of epidural technique in post-operative pain management continues to decrease, ITM has emerged as the neuraxial technique of choice for pain management after a major surgery as a component of multimodal analgesia in Enhanced Recovery After Surgery (ERAS) protocols. ITM is recommended by many scientific groups and societies such as ERAS, PROSPECT, the National Institute for Health and Care Excellence and the Society of Obstetric Anesthesiology and Perinatology. The doses of ITM have decreased successively; today they are a fraction of those used in the early 1980s. With these dose reductions, the risks have decreased; current evidence shows that the risk of the much-feared respiratory depression with low-dose ITM (up to 150 mcg) is no greater than that with systemic opioids used in routine clinical practice. Patients receiving low-dose ITM can be nursed in regular surgical wards. The monitoring recommendations from societies such as the European Society of Regional Anaesthesia and Pain Therapy (ESRA), the American Society of Regional Anesthesia and Pain Medicine and the American Society of Anesthesiologists need to be updated so that the requirements for extended or continuous monitoring at postoperative care units (PACUs), step-down units, high-dependency units, and intensive care units can be eliminated, thereby reducing additional costs and inconvenience and making this simple, versatile and highly effective analgesia technique available to a wider patient population in resource-limited settings.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
鞘内阿片类药物治疗术后疼痛
鞘内阿片类药物在治疗术后疼痛方面非常有效。该技术简单,技术故障或并发症的风险非常低,不需要额外的培训或昂贵的设备,如超声波机,因此在世界各地广泛应用。高质量的疼痛缓解与感觉、运动或自主神经缺陷无关。这项研究的重点是鞘内吗啡(ITM),它是美国食品和药物管理局唯一批准用于鞘内给药的阿片类药物,也是最常用和广泛研究的阿片。ITM的使用与各种手术后持续20-48小时的延长镇痛有关。ITM在胸外科、腹部外科、脊柱外科、泌尿外科和整形外科有着公认的作用。它被认为是剖腹产的“金标准”镇痛技术,通常在脊椎麻醉下进行。随着硬膜外技术在术后疼痛管理中的作用不断减少,ITM已成为大手术后疼痛管理的首选神经轴技术,作为术后增强恢复(ERAS)方案中多模式镇痛的组成部分。ITM由许多科学团体和协会推荐,如ERAS、PROSPECT、国家健康与护理卓越研究所和产科麻醉与围产期学会。ITM的剂量逐渐减少;如今,它们只是20世纪80年代初使用的一小部分。随着这些剂量的减少,风险降低了;目前的证据表明,低剂量ITM(高达150 mcg)引起令人担忧的呼吸抑制的风险并不大于常规临床实践中使用的全身性阿片类药物。接受低剂量ITM治疗的患者可以在常规外科病房接受护理。欧洲区域麻醉和疼痛治疗学会(ESRA)、美国区域麻醉和痛苦医学学会和美国麻醉师学会等学会的监测建议需要更新,以便在术后护理单元(PACU)、降压单元、高依赖性单元、,并且可以取消重症监护室,从而减少额外的成本和不便,并使这种简单、通用和高效的镇痛技术在资源有限的环境中可用于更广泛的患者群体。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
37
审稿时长
36 days
期刊最新文献
Editorial Board Non-neuraxial labour analgesia Preeclampsia and eclampsia: Enhanced detection and treatment for morbidity reduction Initiation and maintenance of neuraxial labour analgesia: A narrative review Epidemiology, trends, and disparities in maternal mortality: A framework for obstetric anesthesiologists
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1